Your browser doesn't support javascript.
loading
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience.
Krejci, Marta; Pour, Ludek; Adam, Zdenek; Sandecka, Viera; Stork, Martin; Sevcikova, Sabina; Krejci, Martin; Knechtova, Zdenka; Kral, Zdenek.
Afiliación
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic. krejci.marta@fnbrno.cz.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Adam Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Sandecka V; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Stork M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Sevcikova S; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Knechtova Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Kral Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
Ann Hematol ; 100(10): 2541-2546, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34309714
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bortezomib / Lenalidomida / COVID-19 / Anticuerpos Monoclonales / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bortezomib / Lenalidomida / COVID-19 / Anticuerpos Monoclonales / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: República Checa